AUS-SCAR

🆕💫Systematic review and meta-analysis 33 studies, including 6 RCTs and 27 observational Impact of antibiotic duration in management of diabetic foot osteomyelitis. Duration: ≤6 weeks Vs >6 weeks DFO is heterogeneous disease imho! #IDXposts sciencedirect.com/science/articl…

@ABsteward Important teaching point that whilst most allergies are lost of time, the rule does not apply to #SCAR! We found similar in #DRESS patients! jaci-inpractice.org/article/S2213-…

The @ASIDANZ ASM #Wellington 2024 conference website is live! Challenging Dogma in #ID. See: buff.ly/3LwH7lT #IDTwitter #MedTwitter #infectiousdiseases

Slide 2/2. Proud we @CAAR_Aus were part of history with the vancomycin #DRESS story with @vumc_cdsi_rsch! ❤️ #HLA #drugallergy

Maybe the greatest slide I have seen on the history of #drugallergy in #SCAR by Prof Wen-Hung Chung at #GlobalScarForum. Big call but great slide! 🏆 🥇

It's time to end the era of simple "pre-post" #antimicrobialstewardship studies. JPIAMR Working Group on Design of Antimicrobial Stewardship Evaluations: "quasi-experimental evaluations of stewardship interventions must always account for changes in time" doi.org/10.1016/j.cmi.…

Join us for the @AAAAI_org Webinar starting at 6pm ET! Such an amazing opportunity to share our passion for Ex vivo/ In vitro Testing #Delayed #Drug #Hypersensitivity @JasonTrubiano @CAAR_Aus @AllergyMuhc @McGill_DOM Registration is free for members #group-tabs-node-course-default1" target="_blank" rel="nofollow noopener">education.aaaai.org/drug-insect-al…

Help revolutionise how #allergyresearch is conducted and translated in Australia. ✔️ Access tools and resources to accelerate your #allergyresearch ✔️Promote your research on the NACE Allergy Studies Directory ✔️Membership is free Sign up today 👉 nace.org.au/about/join-nace

Thank you for the opportunity to present our #drugallergy research and overview of my fellowship training @CAAR_Aus @Austin_Health with @TrubianoJason during the Quebec Allergy-Immunology Association meeting. So exciting to discuss the future of #drugallergy in our practice.

#SCAR are a group of life-threatening conditions with high-morbidity. Clinicians involved in the management can include #allergy/immunology, #dermatology, #infectious diseases, #general internists or #paediatricians. Answer the survey below to learn more

#SCAR #DHS2023 @TrubianoJason @CAAR_Aus @id_austin discussing @aus_scar - the first 100 patients #drugallergy @Austin_Health @CAAR_Aus @TheDohertyInst

#GreatRead: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR) [James F, Goh MSY, Mouhtouris E, Vogrin S, Chua KYL, Holmes NE, Awad A, Copaescu AM, De Luca JF et al. BMJ Open. 2022;12(8):e055906] @AnaCopaescu @DrJoeDeluca @TrubianoJason bmjopen.bmj.com/content/bmjope…

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)-Recuriting at 13 sites & more to come! If you an 🇦🇺 site, interested in #SCAR & want to help these #rarediseases contact us! ⁦⁦@CAAR_Aus⁩ ⁦@TrubianoJason⁩ ncbi.nlm.nih.gov/pubmed/35977774

An International clinician, patient or scientist interested in #drugallergy #penicillinallergy #SCAR?! Then don’t miss…. Challenging Allergy - Drug Hypersensitivity Symposium 2023. Virtual registration available! ⁦@TrubianoJason⁩ @TheDohertyInst⁩ eventbrite.com.au/e/challenging-…

Registration and ABSTRACT submissions open for #DHS2023 - If you are a researcher in SCAR it's a unique opportunity to submit your abstracts for Day 1! #drugallergy #antibioticallergy #SCAR @aus_scar @Austin_Health @TheDohertyInst eventbrite.com.au/e/challenging-…

#DHS2023 Registrations Open Now! Day 1 focuses on SCAR - from science to solutions for #SJS #TEN #AGEP #DRESS. Amazing line up of local & international experts. Opportunity for new science in lightening talks- stay tuned for details! #drugallergy #SCAR @CAAR_Aus @TheDohertyInst

Thank you @GairdnerAwards for this opportunity! As we are completing the @PALACE_Trial - a reminder of how we can improve patient care by focusing on #penicillin allergy. youtube.com/watch?v=DWZ9ZS…

1/Excited to share a case-control study using #EHR data from @MassGenBrigham: vanc #DRESS vs vanc exposed without #DRESS (@mgh_id @bwh_id OPAT patients) #inpress @JAMADerm @NIAIDFunding @MonganInstitute @MGH_ClinEpi @MGHAllergy jamanetwork.com/journals/jamad…

Well done to our @CAAR_Aus Fellow @Jamie_L_Waldron 👏 Questioning the rules in #DRESS secondary to beta-lactam 💊. Latency likely to be phenotype (e.g DRESS) and drug specific (e.g glycopeptides vs penicillins). Still much to learn in #SCAR. @CIDJournal @id_austin @aus_scar

Reviewed a lovely #SCAR patient in clinic, reminded of what a devestating disease #DRESS can be…. 😞 But yet no 🇦🇺 Consumer or Patient Advocacy group! Time for #SCAR Foundation in Aus?!? @DRESSFoundation @NACEresearch @CAAR_Aus @ascia_news